programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
programma definitivo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5<br />
N<br />
O<br />
V<br />
E<br />
M<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
SCLEROSI MULTIPLA 4<br />
Moderatori<br />
R. BERGAMASCHI (Pavia) - A. BERTOLOTTO (Torino)<br />
729. LOW INTER-RATER AGREEMENT IN CHRONIC CEREBROSPINAL VENOUS<br />
INSUFFICIENCY (CCSVI)<br />
O. RAYMKULOVA, A. LUCENTI, A. STECCO, L. BOLAMPERTI, L. COPPO, W. LIBONI, G.<br />
RIVADOSSI, G. ZACCALA, M. MAGGIO, F. MELIS, C. GIACCONE, A. CARRIERO, P.<br />
LOCHNER, M. LEONE (Novara)<br />
730. OUTCOME OF ISOLATED ACUTE TRANSVERSE MYELITIS AND<br />
PREDICTIVE FACTORS FOR CONVERSION TO MULTIPLE SCLEROSIS<br />
V. MARIANI, E. AMBROSONI, M. MONTAGNA, M. MAURI, P. BANFI (Varese)<br />
731. CHARACTERIZATION OF HUMORAL RESPONSE TO EPSTEIN-BARR<br />
NUCLEAR ANTIGEN-1 IN PATIENTS WITH MULTIPLE SCLEROSIS<br />
R. MECHELLI, F. PRATESI, D. VITTORI, C. POLICANO, C. BUSCARINU, V. RICIGLIANO,<br />
P. MIGLIORINI, G. RISTORI, M. SALVETTI (Roma, Pisa)<br />
732. MEANING OF TH22 EXPANSION IN MULTIPLE SCLEROSIS DISEASE<br />
ACTIVITY<br />
S. DE MERCANTI, M. CLERICO, S. ROLLA, V. BARDINA, P. QUAGLINO, R. DE PALMA,<br />
F. PIAZZA, D. GNED, F. NOVELLI, L. DURELLI (Orbassano - TO, Torino, Napoli)<br />
733. ATTITUDES TOWARDS CLINICAL TRIALS IN MS PATIENTS: LEARNING<br />
FROM CCSVI<br />
S. MAIDA, M. MESSINA, M. ROMEO, F. POSSA, G. COMI, V. MARTINELLI (Milano)<br />
734. THE EFFICACY OF NATALIZUMAB AND FINGOLIMOD ON COGNITION<br />
IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS<br />
C.G. CHISARI, C. LEONE, S. CILIA, S. MESSINA, V. CIMINO, F. MASUZZO, S. LO FERMO,<br />
F. PATTI, M. ZAPPIA (Catania)<br />
735. PATTERNS OF GREY MATTER DAMAGE IN PROGRESSIVE MS: A VOXEL-<br />
BASED MORPHOMETRY STUDY VERSUS MOTOR NEURON DISORDERS<br />
E. TAVAZZI, M. LAGANÀ, N. BERGSLAND, P. TORTORELLA, G. PINARDI, C. LUNETTA,<br />
G. BASELLI, M. CORBO, M. ROVARIS (Milano)<br />
736. EMPLOYMENT STATUS AND MULTIPLE SCLEROSIS: RESULTS FROM<br />
A LITERATURE REVIEW<br />
M. LEONARDI, S. SCHIAVOLIN, A. GIOVANNETTI, V. COVELLI, A. RAGGI, L. BRAMBILLA,<br />
R. FRANGIAMORE, M. MOSCATELLI, V. TORRI, R. MANTEGAZZA, P. CONFALONIERI<br />
(Milano)<br />
737. PREDICTORS OF QUALITY OF LIFE AND DISABILITY IN MULTIPLE<br />
SCLEROSIS: IMPACT OF MENTAL HEALTH ISSUES<br />
M. LEONARDI, A. RAGGI, A. GIOVANNETTI, V. COVELLI, S. SCHIAVOLIN, R. MANTEGAZZA,<br />
V. TORRI, L. BRAMBILLA, R. FRANGIAMORE, M. MOSCATELLI, P. CONFALONIERI (Milano)<br />
738. PERSISTENCE OF EFFICACY IN MULTIPLE SCLEROSIS PATIENTS DURING<br />
FINGOLIMOD THERAPY AFTER SWITCH FROM NATALIZUMAB<br />
R. CERQUA, M. DANNI, S. ZAGAGLIA, R. TAFFI, V. MIRISOLA, L. PROVINCIALI (Ancona,<br />
Genova)<br />
739. HEALTH-RELATED QUALITY OF LIFE, FATIGUE, AND UNCERTAINTY<br />
IN A POPULATION-BASED SAMPLE OF PEOPLE WITH MULTIPLE<br />
SCLEROSIS: PRELIMINARY DATA<br />
L. SPADARO, L. GITTO, G. POLIMENI, G. VENUTI, G. D’ALEO, C. RIFICI, E. SESSA,<br />
P. BRAMANTI (Messina, Roma)<br />
190